Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 199.20

+0.1%

Nov 21 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: squetch who wrote (11963)	12/2/1997 9:16:00 AM
From: Hippieslayer	Read Replies (4) of 32384

LGND has sent out to Dermatologists a letter from Dr. Richard C Yokum regarding Targretin oral capsules and top. gels for CTCL. LGND also attached the abstract from the June Int. Soc. for CTSL conference in Sydney. LGND, in essence, is asking Derms for patients that might qualify for LGNDs expanded phase 3 for Targ. Gel and PII/III for Targ. capsules. According to the letter from Dr Yocum ( he is the medical director of clinical research) LGND has 25 study centers in the us and Canada and will be expanding studies in Europe and Australia.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next